Trials / Unknown
UnknownNCT04460131
Soluble ST2 and Cardiovascular Outcome
Association Between Soluble ST2 and Cardiovascular Outcome After Cardiovascular Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
Cardiac surgery induces hemodynamic stress on the myocardium, and this process can be associated with significant cardiovascular morbidity and mortality. Soluble suppression of tumorigenicity 2 (sST2) is biomarker of myocardial remodeling and fibrosis; however, little is known regarding their potential association with cardiovascular events. This study aimed to investigate the release of sST2 and its association with cardiovascular events undergoing cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | soluble ST2 | Serum sST2 was measured on a monoclonal electrochemiluminescence immunoassay. Samples were exposed to two freeze cycles before analysed. Samples were exposed to two thawfreeze cycles before analysed. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2020-07-07
- Last updated
- 2022-04-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04460131. Inclusion in this directory is not an endorsement.